RTW Investments’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40,211
Closed -$280K 78
2025
Q2
$280K Buy
+40,211
New +$369K ﹤0.01% 71
2025
Q1
Sell
-456,772
Closed -$4.57M 74
2024
Q4
$4.57M Hold
456,772
0.07% 61
2024
Q3
$7.54M Hold
456,772
0.11% 53
2024
Q2
$5.07M Hold
456,772
0.08% 55
2024
Q1
$6.03M Buy
456,772
+23,246
+5% +$302K 0.09% 59
2023
Q4
$6.5M Hold
433,526
0.1% 55
2023
Q3
$6.37M Buy
433,526
+4,080
+1% +$78.4K 0.13% 53
2023
Q2
$10.8M Hold
429,446
0.21% 47
2023
Q1
$6.4M Buy
429,446
+43,317
+11% +$804K 0.13% 47
2022
Q4
$5.41M Buy
386,129
+109,932
+40% +$3M 0.11% 57
2022
Q3
$8.73M Hold
276,197
0.2% 56
2022
Q2
$9.58M Buy
276,197
+5,646
+2% +$362K 0.25% 60
2022
Q1
$30.6M Buy
270,551
+99,004
+58% +$11.5M 0.63% 43
2021
Q4
$16.4M Buy
171,547
+34,466
+25% +$3.1M 0.24% 75
2021
Q3
$12.1M Buy
137,081
+45,000
+49% +$4.43M 0.18% 73
2021
Q2
$11.3M Hold
92,081
0.17% 70
2021
Q1
$14.7M Hold
92,081
0.23% 63
2020
Q4
$14.1M Buy
92,081
+831
+0.9% +$149K 0.24% 62
2020
Q3
$16.9M Buy
+91,250
New +$14.9M 0.41% 55

Other funds holding IMUX

RTW Investments's IMUX Position: Q3 2025 in Review

RTW Investments sold out of Immunic (IMUX) in Q3 2025, closing a stake of 40,211 shares — an estimated $280K sold.

RTW Investments first reported a position in IMUX in Q3 2020 and held it in 19 quarters. The position peaked at $30.6M in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

  • RTW Investments reported no remaining Immunic position as of Q3 2025 after selling out during the quarter.
  • RTW Investments sold 40,211 Immunic shares in Q3 2025, an estimated $280K.
  • RTW Investments first reported a position in Immunic in Q3 2020 and held it in 19 quarters.
  • RTW Investments's Immunic position peaked at $30.6M in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on RTW Investments's 13F filing for Q3 2025, filed 14 Nov 2025.